Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2014; 24 (1): 18-22
in English | IMEMR | ID: emr-147120

ABSTRACT

To determine the accuracy of serum alpha fetoprotein [AFP] for diagnosis of hepatocellular carcinoma [HCC] in patients with cirrhosis. Observational study. Department of Medicine, The King Edward Medical University, Lahore, from November 2007 to August 2011. Consecutive patients, diagnosed with HCC by contrast enhanced CT, MRI or biopsy were included as cases. Patients of cirrhosis with no evidence of HCC were enrolled as controls. Demographic, laboratory and radiological data were recorded. Serum AFP was determined in all patients at outset and was analyzed using ROC curve for its accuracy in diagnosing HCC. A total of 275 patients were included; of them 173 had HCC and 102 had cirrhosis. One hundred and thirty nine cases [80.3%] with HCC and 86 [84.3%] without HCC had cirrhosis due to HCV. Stage of liver disease, as determined by Child Turcotte Pugh [CTP] score, was comparable; mean CTP value 7.97 A +/- 2.17 in HCC and 7.75 A +/- 2.21 in control group [p = 0.41]. Area under curve [AUC] for AFP was 0.85 [95%, CI: 0.80 - 0.90] with optimum cut off value of 20.85 ng/ml which showed 72.2% sensitivity, 86.2% specificity, 89.9% positive predictive value, 64.7% negative predictive value and 77.4% overall accuracy in diagnosing patients with HCC. Despite sub-optimal sensitivity, alpha fetoprotein is still a valid screening test for diagnosis of hepatocellular carcinoma till other more sensitive markers are developed. Till then, it should be used in conjunction with ultrasound

2.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2012; 22 (2): 131-132
in English | IMEMR | ID: emr-162697
3.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2008; 18 (11): 684-687
in English | IMEMR | ID: emr-87536

ABSTRACT

To determine the efficacy of L-ornithine-L-aspartate in treatment of hepatic encephalopathy. Randomized, placebo-controlled trial. Department of Gastroenterology and Hepatology, Sheikh Zayed Hospital, Lahore, from February to August 2005. Cirrhotic patients with hyperammonemia and overt hepatic encephalopathy were enrolled. Eighty patients were randomized to two treatment groups, L-ornithine-L-aspartate [20g/d] or placebo, both dissolved in 250mL of 5% dextrose water and infused intravenously for four hours a day for five consecutive days with 0.5 g/kg dietary protein intake at the end of daily treatment period. Outcome variables were postprandial blood ammonia and mental state grade. Adverse reactions and mortality were also determined. Both treatment groups were comparable regarding age, gender, etiology of cirrhosis, Child-Pugh class, mental state grade and blood ammonia at baseline. Although, improvement occurred in both groups, there was a greater improvement in L-ornithine-L-aspartate group with regard to both variables. Four patients in the placebo group and 2 in L-ornithine-L-aspartate group died. L-ornithine-L-aspartate infusions were found to be effective in cirrhotic patients with hepatic encephalopathy


Subject(s)
Humans , Male , Female , Hepatic Encephalopathy/physiopathology , Ammonia/blood , Cognition , Dipeptides , Dipeptides/administration & dosage , Hyperammonemia/drug therapy , Liver Cirrhosis/complications , Postprandial Period/drug effects
4.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2008; 18 (11): 726-727
in English | IMEMR | ID: emr-87547

ABSTRACT

A 52 years old lady was admitted with 2 weeks history of abdominal distension and drowsiness. Laboratory workup confirmed the presence of de-compensated liver disease with negative viral serology. Abdominal ultrasound and CT abdomen revealed tumour in right kidney with tumour thrombus extending in inferior vena cava and hepatic vein resulting in Budd Chiari syndrome and ascites. Patient was managed with medications only due to advanced liver disease


Subject(s)
Humans , Female , Kidney Neoplasms/physiopathology , /etiology , /diagnosis , /drug therapy , /physiopathology , Hepatic Veins/pathology , Ascites/pathology , Thromboembolism/etiology , Thromboembolism/drug therapy , Vena Cava, Inferior/pathology
SELECTION OF CITATIONS
SEARCH DETAIL